Veröffentlichungen der Arbeitsgruppe

  1. Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B, Gruenberger T.
    Sinusoidal Obstruction Syndrome Impairs Long-Term Outcome of Colorectal Liver Metastases Treated with Resection after Neoadjuvant Chemotherapy.
    Ann SurgOncol. 2010 Sep 16. [Epub ahead of print] PubMed PMID: 20844968.
  2. Klinger M, Tamandl D, Eipeldauer S, Hacker S, Herberger B, Kaczirek K, Dorfmeister M, Gruenberger B, Gruenberger T.
    Bevacizumabimprovespathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.
    Ann SurgOncol. 2010 Aug;17(8):2059-65. Epub 2010 Feb 23. PubMed PMID: 20177795.
  3. Tamandl D, Gruenberger B, Klinger M, Herberger B, Kaczirek K, Fleischmann E, Gruenberger T.
    Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study.
    Ann Surg. 2010 Jul;252(1):124-30. PubMed PMID: 20562613.
  4. Van Cutsem E, Dicato M, Arber N, Berlin J, Cervantes A, Ciardiello F, De Gramont A, Diaz-Rubio E, Ducreux M, Geva R, Glimelius B, Glynne Jones R, Grothey A, Gruenberger T, Haller D, Haustermans K, Labianca R, Lenz HJ, Minsky B, Nordlinger B, Ohtsu A, Pavlidis N, Rougier P, Schmiegel W, Van de Velde C, Schmoll HJ, Sobrero A, Tabernero J.
    Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.
    Ann Oncol. 2010 Jun;21Suppl 6:vi1-10. PubMed PMID: 20534623.
  5. Starlinger P, Moll HP, Assinger A, Nemeth C, Hoetzenecker K, Gruenberger B, Gruenberger T, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C.
    Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. J ThrombHaemost.
    2010 May 12. [Epub ahead of print] PubMed PMID: 20492458.
  6. Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F, Weber M, Ba-Ssalamah A.
    Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
    Eur J Radiol. 2010 Apr 12. [Epub ahead of print] PubMed PMID: 20392584.
  7. Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, Pitton M, Sergent G, Pfammatter T, Terraz S, Benhamou Y, Avajon Y, Gruenberger T, Pomoni M, Langenberger H, Schuchmann M, Dumortier J, Mueller C, Chevallier P, Lencioni R; PRECISION V Investigators.
    Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. CardiovascInterventRadiol.
    2010 Feb;33(1):41-52. Epub 2009 Nov 12. PubMed PMID: 19908093; PubMed Central PMCID: PMC2816794.
  8. Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, Lang H, Frilling A, Stoehlmacher J, Weitz J, Konopke R, Stroszczynski C, Liersch T, Ockert D, Herrmann T, Goekkurt E, Parisi F, Köhne CH.
    Tumour response and secondaryresectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
    Lancet Oncol. 2010 Jan;11(1):38-47. Epub 2009 Nov 26. PubMed PMID: 19942479.
  9. Tamandl D, Gruenberger B, Herberger B, Kaczirek K, Gruenberger T.
    Surgery afterneoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients.
    J SurgOncol. 2009 Oct 1;100(5):364-71. PubMed PMID: 19235181.
  10. Kaczirek K, Tamandl D, Klinger M, Gruenberger T.   
    Criteria for resectability of colorectal cancer liver metastases – an Austrian survey and current recommendations.
    EurSurg. 2009; 41: 213-220
  11. Tamandl D, Kaczirek K, Gruenberger B, Koelblinger C, Maresch J, Jakesz R, Gruenberger T.
    Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma.
    Br J Surg. 2009 Aug;96(8):919-25. PubMed PMID: 19591163.
  12. Verslype C, Van Cutsem E, Dicato M, Arber N, Berlin JD, Cunningham D, De Gramont A, Diaz-Rubio E, Ducreux M, Gruenberger T, Haller D, Haustermans K, Hoff P, Kerr D, Labianca R, Moore M, Nordlinger B, Ohtsu A, Rougier P, Scheithauer W, Schmoll HJ, Sobrero A, Tabernero J, van de Velde C.
    The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
    Ann Oncol. 2009 Jun;20Suppl 7:vii1-vii6. PubMed PMID: 19497945.
  13. Nordlinger B, Van Cutsem E, Gruenberger T, Glimelius B, Poston G, Rougier P, Sobrero A, Ychou M; European Colorectal Metastases Treatment Group; Sixth International Colorectal Liver Metastases Workshop.
    Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel.
    Ann Oncol. 2009 Jun;20(6):985-92. Epub 2009 Jan 19. PubMed PMID: 19153115.
  14. Herberger B, Berger W, Puhalla H, Schmid K, Novak S, Brandstetter A, Pirker C, Gruenberger T, Filipits M.
    Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cells.
    Mol Cancer Ther. 2009 Jun;8(6):1547-56. Epub 2009 Jun 9. PubMed PMID: 19509244.
  15. Klinger M, Eipeldauer S, Hacker S, Herberger B, Tamandl D, Dorfmeister M, Koelblinger C, Gruenberger B, Gruenberger T.
    Bevacizumabprotectsagainst sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases.
    Eur J SurgOncol. 2009 May;35(5):515-20. Epub 2009 Feb 5. PubMed PMID: 19200687.
  16. Fleischmann E, Marschalek C, Schlemitz K, Dalton JE, Gruenberger T, Herbst F, Kurz A, Sessler DI.
    Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial. BMC Anesthesiol.
    2009 Feb 3;9:1. PubMed PMID: 19192300; PubMed Central PMCID: PMC2660895.
  17. Haghighi KS, Glenn D, Gruenberger T, Morris DL.
    Extending the limits for curative liver resections by portal vein embolization.
    Int Surg. 2009 Jan-Feb;94(1):43-7. PubMed PMID: 20099426.
  18. Kovar FM, Thallinger C, Marsik CL, Perkmann T, Puhalla H, Haslacher H, Wrba F, Wagner OF, Gruenberger T, Endler G.
    The EGF 61A/G polymorphism – a predictive marker for recurrence of liver metastases from colorectal cancer.
    Wien Klin Wochenschr. 2009;121(19-20):638-43. PubMed PMID: 19921131.
  19. Kandutsch S, Klinger M, Hacker S, Wrba F, Gruenberger B, Gruenberger T.
    Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.
    Eur J SurgOncol. 2008 Nov;34(11):1231-6. Epub 2008 Feb 12. PubMed PMID: 18272318.
  20. Poston GJ, Figueras J, Giuliante F, Nuzzo G, Sobrero AF, Gigot JF, Nordlinger B, Adam R, Gruenberger T, Choti MA, Bilchik AJ, Van Cutsem EJ, Chiang JM, D’Angelica MI.
    Urgent need for a new staging system in advanced colorectal cancer.
    J ClinOncol. 2008 Oct 10;26(29):4828-33. Epub 2008 Aug 18. PubMed PMID: 18711170.
  21. Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T.
    Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Ann SurgOncol. 2008 Oct;15(10):2787-94. Epub 2008 Aug 7. PubMed PMID: 18685896.
  22. Tamandl D, Herberger B, Gruenberger B, Schoppmann SF, Puhalla H, Schindl M, Schima W, Jakesz R, Gruenberger T.
    Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases.
    Surgery. 2008 May;143(5):648-57. Epub 2008 Jan 30. PubMed PMID: 18436013.
  23. Gruenberger B, Scheithauer W, Punzengruber R, Zielinski C, Tamandl D, Gruenberger T.
    Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases.
    BMC Cancer. 2008 Apr 25;8:120. PubMed PMID: 18439246; PubMed Central PMCID: PMC2386791.
  24. Gruenberger B, Tamandl D, Schueller J, Scheithauer W, Zielinski C, Herbst F, Gruenberger T.
    Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.
    J ClinOncol. 2008 Apr 10;26(11):1830-5. PubMed PMID: 18398148.
  25. Brostjan C, Gebhardt K, Gruenberger B, Steinrueck V, Zommer H, Freudenthaler H, Roka S, Gruenberger T.
    Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels.
    Clin Cancer Res. 2008 Apr 1;14(7):2065-74. PubMed PMID: 18381946.
  26. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD).
    Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.
    Lancet. 2008 Mar 22;371(9617):1007-16. PubMed PMID: 18358928; PubMed Central PMCID: PMC2277487.
  27. Kabon B, Kugener A, Gruenberger T, Niedermayr M, Fleischmann E, Freissmuth M, Kurz A.
    Effects of continuous remifentanil administration on intra-operative subcutaneous tissue oxygen tension. Anaesthesia.
    2007 Nov;62(11):1101-9. PubMed PMID: 17924889.
  28. Schima W, Ba-Ssalamah A, Kurtaran A, Schindl M, Gruenberger T.
    Post-treatment imaging of liver tumours. Cancer Imaging. 2007 Oct 1;7 Spec No A:S28-36. Review.
    PubMed PMID: 17921098; PubMed Central PMCID: PMC2727978.
  29. Bodingbauer M, Tamandl D, Schmid K, Plank C, Schima W, Gruenberger T.
    Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases.
    Br J Surg. 2007 Sep;94(9):1133-8. PubMed PMID: 17514637.
  30. Nordlinger B, Van Cutsem E, Rougier P, Köhne CH, Ychou M, Sobrero A, Adam R, Arvidsson D, Carrato A, Georgoulias V, Giuliante F, Glimelius B, Golling M, Gruenberger T, Tabernero J, Wasan H, Poston G; European Colorectal Metastases Treatment Group.
    Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group.
    Eur J Cancer. 2007 Sep;43(14):2037-45. Epub 2007 Sep 4. Review. PubMed PMID: 17766104.
  31. Herberger B, Puhalla H, Lehnert M, Wrba F, Novak S, Brandstetter A, Gruenberger B, Gruenberger T, Pirker R, Filipits M.
    Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma.
    Clin Cancer Res. 2007 Aug 15;13(16):4795-9. PubMed PMID: 17699857.
  32. Puhalla H, Wrba F, Kandioler D, Lehnert M, Huynh A, Gruenberger T, Tamandl D, Filipits M.
    Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
    Anticancer Res. 2007 May-Jun;27(3B):1679-84. PubMed PMID: 17595796.
  33. Tamandl D, Gruenberger B, Herberger B, Schoppmann S, Bodingbauer M, Schindl M, Puhalla H, Fleischmann E, Schima W, Jakesz R, Laengle F, Gruenberger T.
    Selective resection of colorectal liver metastases.
    Eur J SurgOncol. 2007 Mar;33(2):174-82. Epub 2006 Oct 12. PubMed PMID: 17046194.
  34. Gruenberger T, Gruenberger B, Scheithauer W.
    Neoadjuvanttherapywith bevacizumab.
    J ClinOncol. 2006 Jun 1;24(16):2592-3; author reply 2593-4.
    Erratum in: J ClinOncol. 2006 Aug 10;24(23):3814. PubMed PMID: 16735714.
  35. Schuell B, Gruenberger T, Scheithauer W, Zielinski Ch, Wrba F.
    HER 2/neu protein expression in colorectal cancer.
    BMC Cancer. 2006 May 8;6:123. PubMed PMID: 16681853; PubMed Central PMCID: PMC1475876.
  36. Puhalla H, Herberger B, Soleiman A, Filipits M, Laengle F, Gruenberger T, Wrba F.
    E-cadherin and beta-catenin expression in normal, inflamed and cancerous gallbladder tissue.
    Anticancer Res. 2005 Nov-Dec;25(6B):4249-54. PubMed PMID: 16309224.
  37. Schuell B, Gruenberger T, Kornek GV, Dworan N, Depisch D, Lang F, Schneeweiss B, Scheithauer W.
    Side effects during chemotherapy predict tumour response in advanced colorectal cancer.
    Br J Cancer. 2005 Oct 3;93(7):744-8. PubMed PMID: 16160693; PubMed Central PMCID: PMC2361647.
  38. Puhalla H, Schuell B, Pokorny H, Kornek GV, Scheithauer W, Gruenberger T.
    Treatment and outcome of intrahepatic cholangiocellular carcinoma.
    Am J Surg. 2005 Feb;189(2):173-7. PubMed PMID: 15720985.
  39. Gruenberger T.
    [Surgical requirements for radiological diagnostics of liver pathologies]. Radiologe.
    2004 Dec;44(12):1154-9. Review.German. PubMed PMID: 15549224.
  40. Kornek GV, Schuell B, Laengle F, Gruenberger T, Penz M, Karall K, Depisch D, Lang F, Scheithauer W.
    Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.
    Ann Oncol. 2004 Mar;15(3):478-83. PubMed PMID: 14998852.
  41. Puhalla H, Kandioler D, Ludwig C, Filipits M, Wrba F, Laengle F, Jakesz R, Gruenberger T.
    p53 analysis in gallbladder cancer: comparison of gene analysis versus immunohistochemistry.
    Anticancer Res. 2004 Mar-Apr;24(2C):1201-6. PubMed PMID: 15154647.
  42. Puhalla H, Gruenberger T, Pokorny H, Soliman T, Wrba F, Sponer U, Winkler T, Ploner M, Raderer M, Steininger R, Mühlbacher F, Laengle F.
    Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis.
    World J Surg. 2003 Jun;27(6):680-4. Epub 2003 May 13. PubMed PMID: 12733000.
  43. Puhalla H, Wild T, Bareck E, Pokorny H, Ploner M, Soliman T, Stremitzer S, Depisch D, Laengle F, Gruenberger T.
    Long-term follow-up of surgically treated gallbladder cancer patients.
    Eur J SurgOncol. 2002 Dec;28(8):857-63. PubMed PMID: 12477478.
  44. Morris DL, Jourdan JL, Finlay I, Gruenberger T, The MP, Pourgholami MH.
    Hepatic intra-arterial injection of 1,25-dihydroxyvitamin D3 in lipiodol: Pilot study in patients with hepatocellular carcinoma.
    Int J Oncol. 2002 Oct;21(4):901-6. PubMed PMID: 12239633.
  45. Gruenberger T, Zhao J, King J, Chung T, Clingan PR, Morris DL.
    Echogenicity of liver metastases from colorectal carcinoma is an independent prognostic factor in patients treated with regional chemotherapy.
    Cancer. 2002 Mar 15;94(6):1753-9. PubMed PMID: 11920538.
  46. Gruenberger T, Morris DL. S
    taged treatment of bilobar hepatic metastases from colorectal cancer.
    Eur J Surg. 2002;168(8-9):516-8. PubMed PMID: 12549697.
  47. Gruenberger T, Jourdan JL, Zhao J, King J, Morris DL.
    Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases.
    Arch Surg. 2001 Oct;136(10):1154-7. PubMed PMID: 11585508.
  48. Gruenberger T, Jourdan JL, Zhao J, King J, Morris DL.
    Echogenicity of liver metastases is an independent prognostic factor after potentially curative treatment.
    Arch Surg. 2000 Nov;135(11):1285-90. PubMed PMID: 11074882.